The lab-based IVD market size was valued at USD 42.54 billion in 2024 and is expected to reach USD 67.03 billion by 2032, growing at a CAGR of 5.87% over 2025-2032.
The global lab-based IVD market is growing at a fast pace, driven by the growing prevalence of chronic diseases, awareness of early diagnosis, and technological advancements in testing. Growing geriatric population and increased use of molecular diagnostics are impelling demand for lab-based IVDs, particularly in developed regions, such as the U.S. The U.S. lab-based IVD market has witnessed a jump in the adoption rate on account of the rising penetration of health insurance and favorable reimbursement plans.
Abbott introduced its Alinity m STI assay in April 2024, which is capable of detecting CT/NG/MG/TV at the same time in the same assay (multiplexed diagnostics is becoming mainstream in the lab-based IVD market).
Indeed, one of the main drivers of market expansion has been Medicare’s broad coverage of lab tests based on next-generation sequencing (NGS). Furthermore, the OECD states that global R&D investment in health and well-being totaled over USD 220 billion in 2023, much of which was indirectly earmarked for diagnostic innovation. Investment activity has also been impressive. VC investment in diagnostics topped USD 6 billion in 2023. Regulators, such as the FDA, are accelerating lab-developed test (LDT) approvals, improving the accuracy and pace of clinical diagnostics. This sort of regulatory certainty is also prompting lab-based IVD companies to ramp up product pipelines and clinical trials, as evidenced by both Roche and Abbott, which each grew their lab-based testing platforms in 2024. Moreover, the lab-based IVD market analysis reads of quick uptake in liquid biopsies and infectious disease testing, driven by increased post-pandemic monitoring.
CE-IVDR clearance of its extended digital pathology offering was obtained by Roche Diagnostics in May 2024, marking a move toward AI-enhanced diagnostics driving the global lab-based IVD market.
Market Dynamics:
Drivers:
Technological Innovation, Precision Diagnostics, And Healthcare Digitization Are Fueling the Lab-Based IVD Market Growth
Rising demand for early and accurate diagnosis, owing to the surge in non-communicable diseases boosting the lab-based IVD market growth declining share for hospital-based diagnostics. The lab-based IVD is the dominating technique in the global IVD market. Increasing use of molecular diagnostics, immunoassays, and next-generation sequencing in the clinical laboratory is changing the face of diagnostic precision. The lab-based IVD market trends related to laboratory-based IVDs indicate a growing trend toward automation and AI integration in the laboratory workflow.
For instance, Thermo Fisher’s Ion Torrent Genexus Dx Integrated Sequencer, an advanced AI-based automated NGS platform which is scheduled to be launched in 2024, is enabling same-day reporting, improved patient outcomes, and greater lab efficiency.
By contrast, global healthcare R&D spending reached nearly USD 243 billion in 2023, the World Bank states, where an ever-increasing fraction is from diagnostics, due to rising demand. Legislation such as the U.S. VALID Act, which offers clarification on the regulation of lab-developed tests, is also having a favorable effect on adoption, she reported. Further, pandemic-related public and private investments into the lab testing infrastructure and the supply chain stabilization actions have positioned a more responsive lab network to nurture deeper and richer lab-based IVD market analysis. The growing awareness and availability of diagnostics in low- and middle-income countries, in addition to the penetration of digital health, also continue to contribute to the increasing lab-based IVD market in different clinical areas.
Restraints:
Regulatory Complexity, Cost Constraints, and Supply-Chain Inefficiencies are Limiting Adoption in Several Regions, Hampering the Market Expansion
Although the lab-based IVD market is growing strongly, it is constrained by a complex regulatory environment and the high associated costs for developing, validating, and deploying new tests. Regulatory obstacles and inconsistent oversight, especially across international markets, can slow down approval processes.
For instance, increased requirements on the part of the FDA concerning LDTs under the 2024 Final Rule have brought compliance challenges for smaller diagnostic labs.
Additionally, the expense of molecular and genetic testing methods has restricted their availability in resource-limited settings. The average out-of-pocket expense in 2023 for advanced diagnostics tests in developing countries was USD 150-300, resulting in a gap in affordability. Moreover, lab-based IVD market analysis reveals that there continue to be some issues with the supply chain for key reagents and equipment that are delaying sample processing in remote labs. In addition, there is a lack of trained lab professionals predicted to exceed 500,000 as a global gap by 2026 (WHO estimate), leading to capacity bottlenecks.
Such systemic limitations not only lower the efficiency of testing but also limit the expansion of the lab-based IVD market share in low-resource areas. Data privacy concerns, especially for digital diagnostics, continue to hamper adoption downward even as technology makes its mark on lab-based IVD market dynamics.
By Product Type
The reagents & consumables segment held the largest share of the global lab-based IVD market in 2024, which is 63% of the market. This domination is influenced by the repetitive, exploitative use of reagents in high-throughput diagnostic tests, often in clinical laboratories and medical centers. Increasing necessity for credible diagnostic kits and disease-specific testing panels drives the demand.
The instruments segment, in the meantime, is expected to witness the fastest growth, supported by the growing automation, technological advances, and mounting installations of high-throughput diagnostic analyzers in developed and developing health care systems.
By Technique
Immunodiagnostics was the leading technology in 2024, with over 38% of the market share, as it is sensitive, provides quick results, and is widely used for both infectious disease and chronic disease testing.
The market is driven by the rising prevalence of blood-related diseases globally and technological advancements in the field of hematological analyzers that enable multi-parameter testing and provide enhanced accuracy.
By Sample Type
In 2024, the blood sample segment was the largest in the lab-based IVD market, which accounted for 47% of the total share due to the prevalence of use in a number of diagnostic assays, especially in immunodiagnostics, molecular testing, and hematology. Its superiority is further supported due to ease of access and increased diagnostic yield.
Blood segment is also the fastest growing category, owing to its ease of use and compatibility with most of the automated analyzers and multi-analyte tests.
By Application
The market share for infectious diseases accounted for 42% of the global lab-based IVD total. The growth is mainly attributed to the extensive number of tests after the pandemic outbreak, escalated surveillance, and rising demand for effective pathogen detection technologies.
The others application segment, which includes endocrinology, nephrology, and rare disease diagnostics, is expected to register the highest growth rate due to increased clinical awareness, availability of a large number of tests, and the shift toward personalized medicine.
By End-User
Clinical laboratories held more than 54% share of the market in 2024 due to their inclination to perform high-volume and complex tests with specific infrastructure. Their scalability, automation, and integration with hospital systems are some of the reasons they are ahead in the race. This segment is also anticipated to be the fastest-growing due to the increasing demand for centralized diagnostic services and the surge in lab-diagnostics companies' partnerships for specialized testing.
North America held the largest share in the global lab-based IVD market in 2024, with a 38.2% share, owing to advanced healthcare facilities and substantial reimbursement policies, along with an inclination toward sophisticated diagnostic technologies.
The U.S. lab-based IVD market size was valued at USD 12.28 billion in 2024 and is expected to reach USD 17.40 billion by 2032, growing at a CAGR of 4.51% from 2025 to 2032. The U.S. dominates the region following high R&D expenditure, strong regulatory avenues (CLIA and FDA approval), and leading industry players Abbott, Thermo Fisher, and Quest Diagnostics in the region. The U.S. is also a leading adopter of molecular diagnostic and automation platforms in the region, these being other robust contributors to the region, including dominance. There is increasing demand for infectious disease and genetic testing in Canada, in part because of heightened awareness of public health and investment in diagnostics infrastructure. Mexico is seeing greater access to laboratory diagnostics through healthcare reforms and in international collaboration, providing a boost to regional development.
Europe is the second largest region in the global lab-based IVD market, due to the growing elderly population, the national programs of screening, and the high public health care spending. Countries, such as Germany and the U.K. have the largest market for POC testing as there the laboratory networks are very strong plus governments in these regions are investing in diagnostic management practices with a strong focus on early disease diagnosis, prevention, and management with rapid testing techniques that get results within minutes, use of immunodiagnostics and blood tests (hematology testing).
In the early stage, firstly, Germany directly benefits as a capital infrastructure player in computerized and AI-driven laboratory solutions, already 75% of the clinical lab market is already operating with sophisticated diagnostic equipment. Quality and safety standards are bolstered by the CE-IVDR. France and Italy continue to demonstrate demand growth, and Poland and Turkey are investing significantly in the modernization of their healthcare systems, driving regional growth.
The lab-based IVD market in Asia Pacific is expected to grow at the highest CAGR during the forecast period due to the growing patient population, rapidly increasing geriatric population, and favorable government initiatives. China is leading the pack in the region, with aggressive efforts on healthcare digitization, indigenous manufacture of diagnostic devices, and increased public-private partnerships. Since 2022, more than 30% of hospitals in the country have introduced automatic diagnostic laboratories.
India is growing fast on account of the increased focus on preventive healthcare, the proliferation of diagnostics chains, and government schemes, including Ayushman Bharat, where diagnostics is part of public cover. Japan is experiencing continuous growth due to its well-developed healthcare system and high interest in genetic and geriatric testing. South Korea and Singapore have the highest utilization of cutting-edge technologies such as NGS and digital pathology. They also continue to enjoy conducive regulatory environments and innovation-led ecosystems, which propel the region’s good momentum in the lab-based IVD market.
Leading lab-based IVD companies operating in the market are F. Hoffmann-La Roche Ltd., Abbott, Thermo Fisher Scientific Inc., Sysmex Corporation, Siemens Healthineers AG, BD, QIAGEN, Bio-Rad Laboratories Inc., Seegene Inc., DiaSorin S.p.A., and Quest Diagnostics Incorporated.
In April 2025, Seegene unveiled CURECA, its next-generation platform that automates PCR workflows and sample handling, reflecting a broader industry shift toward laboratory efficiency and automation within lab-based IVD market analysis.
In February 2024, Quest Diagnostics introduced MelaNodal Predict, a cutting-edge gene-expression assay designed to personalize melanoma treatment decisions by assessing the risk of lymph node metastasis, highlighting how lab-based IVD market trends increasingly emphasize precision medicine.
| Report Attributes | Details |
|---|---|
| Market Size in 2024 | USD 42.54 billion |
| Market Size by 2032 | USD 67.03 billion |
| CAGR | CAGR of 5.87% From 2025 to 2032 |
| Base Year | 2024 |
| Forecast Period | 2025-2032 |
| Historical Data | 2021-2023 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product Type (Instruments, Reagents, and Consumables) • By Technique (Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Hematology, and Others) • By Sample Type (Blood, Urine, Saliva, Tissue, and Others) • By Application (Infectious Diseases, Cardiology, Oncology, Gastroenterology, Allergy, Autoimmunity, Prenatal Screening, and Others) • By End-User (Hospitals, Clinical Laboratories, and Others) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | F. Hoffmann-La Roche Ltd., Abbott, Thermo Fisher Scientific Inc., Sysmex Corporation, Siemens Healthineers AG, BD, QIAGEN, Bio-Rad Laboratories Inc., Seegene Inc., DiaSorin S.p.A., and Quest Diagnostics Incorporated. |
Ans: The Lab-Based IVD market is anticipated to grow at a CAGR of 5.87% from 2025 to 2032.
Ans: The market is expected to reach USD 67.03 billion by 2032, increasing from USD 42.54 billion in 2024.
Ans: Rising demand for early and accurate diagnosis, owing to the surge in non-communicable diseases boosting the lab-based IVD market growth declining share for hospital-based diagnostics.
Ans: Although the lab-based IVD market is growing strongly, it is constrained by a complex regulatory environment and the high associated costs for developing, validating, and deploying new tests.
Ans: North America dominated the Lab-Based IVD market.
Table of Contents:
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Reimbursement and Pricing Trends (2024), by Region
5.2 Lab Infrastructure and Automation Adoption (2021–2032)
5.3 Healthcare Spending on Lab-Based Diagnostics, by Region (2024)
5.4 Disease Burden Impact on Test Demand (2024)
5.5 Regulatory Approvals and Test Menu Expansion (2023–2024)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and supply chain strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Lab-Based IVD Market Segmentation, By Product Type
7.1 Chapter Overview
7.2 Instruments
7.2.1 Instruments Market Trends Analysis (2021-2032)
7.2.2 Instruments Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Reagents & Consumables
7.3.1 Reagents & Consumables Market Trends Analysis (2021-2032)
7.3.2 Reagents & Consumables Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Lab-Based IVD Market Segmentation, By Technique
8.1 Chapter Overview
8.2 Immunodiagnostics
8.2.1 Immunodiagnostics Market Trends Analysis (2021-2032)
8.2.2 Immunodiagnostics Market Size Estimates And Forecasts To 2032 (USD Billion)
8.3 Clinical Chemistry
8.3.1 Clinical Chemistry Market Trends Analysis (2021-2032)
8.3.2 Clinical Chemistry Market Size Estimates And Forecasts To 2032 (USD Billion)
8.4 Molecular Diagnostics
8.4.1 Molecular Diagnostics Market Trends Analysis (2021-2032)
8.4.2 Molecular Diagnostics Market Size Estimates And Forecasts To 2032 (USD Billion)
2032 (USD Billion)
8.5 Hematology
8.5.1 Hematology Market Trends Analysis (2021-2032)
8.5.2 Hematology Market Size Estimates And Forecasts To 2032 (USD Billion)
2032 (USD Billion)
8.6 Others
8.6.1 Others Market Trends Analysis (2021-2032)
8.6.2 Others Market Size Estimates And Forecasts To 2032 (USD Billion)
2032 (USD Billion)
9. Lab-Based IVD Market Segmentation, By Sample Type
9.1 Chapter Overview
9.2 Blood
9.2.1 Blood Market Trends Analysis (2021-2032)
9.2.2 Blood Market Size Estimates And Forecasts To 2032 (USD Billion)
9.3 Urine
9.3.1 Urine Market Trends Analysis (2021-2032)
9.3.2 Urine Market Size Estimates And Forecasts To 2032 (USD Billion)
9.4 Saliva
9.4.1 Saliva Market Trends Analysis (2021-2032)
9.4.2 Saliva Market Size Estimates And Forecasts To 2032 (USD Billion)
9.5 Tissue
9.5.1 Tissue Market Trends Analysis (2021-2032)
9.5.2 Tissue Market Size Estimates And Forecasts To 2032 (USD Billion)
9.6 Others
9.6.1 Others Market Trends Analysis (2021-2032)
9.6.2 Others Market Size Estimates And Forecasts To 2032 (USD Billion)
10. Lab-Based IVD Market By Application
10.1 Chapter Overview
10.2 Infectious Diseases
10.2.1 Infectious Diseases Market Trends Analysis (2021-2032)
10.2.2 Infectious Diseases Market Size Estimates And Forecasts To 2032 (USD Billion)
10.3 Cardiology
10.3.1 Cardiology Market Trends Analysis (2021-2032)
10.3.2 Cardiology Market Size Estimates And Forecasts To 2032 (USD Billion)
10.4 Oncology
10.4.1 Oncology Market Trends Analysis (2021-2032)
10.4.2 Oncology Market Size Estimates And Forecasts To 2032 (USD Billion)
10.5 Gastroenterology
10.5.1 Gastroenterology Market Trends Analysis (2021-2032)
10.5.2 Gastroenterology Market Size Estimates And Forecasts To 2032 (USD Billion)
10.6 Allergy
10.6.1 Allergy Market Trends Analysis (2021-2032)
10.6.2 Allergy Market Size Estimates And Forecasts To 2032 (USD Billion)
10.7 Autoimmunity
10.7.1 Autoimmunity Market Trends Analysis (2021-2032)
10.7.2 Autoimmunity Market Size Estimates And Forecasts To 2032 (USD Billion)
10.8 Prenatal Screening
10.8.1 Prenatal Screening Market Trends Analysis (2021-2032)
10.8.2 Prenatal Screening Market Size Estimates And Forecasts To 2032 (USD Billion)
10.9 Others
10.9.1 Others Market Trends Analysis (2021-2032)
10.9.2 Others Market Size Estimates And Forecasts To 2032 (USD Billion)
11. Automotive Ambient Lighting Market, By End-User
11.1 Chapter Overview
11.2 Hospitals
11.2.1 Hospitals Market Trends Analysis (2021-2032)
11.2.2 Hospitals Market Size Estimates And Forecasts To 2032 (USD Billion)
11.3 Clinical Laboratories
11.3.1 Clinical Laboratories Market Trends Analysis (2021-2032)
11.3.2 Clinical Laboratories Market Size Estimates And Forecasts To 2032 (USD Billion)
11.4 Others
11.4.1 Others Market Trends Analysis (2021-2032)
11.4.2 Others Market Size Estimates And Forecasts To 2032 (USD Billion)
12. Regional Analysis
12.1 Chapter Overview
12.2 North America
12.2.1 Trends Analysis
12.2.2 North America Lab-Based IVD Market Estimates And Forecasts, By Country (2021-2032) (USD Billion)
12.2.3 North America Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.2.4 North America Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.2.5 North America Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.2.6 North America Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.2.7 North America Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.2.8 USA
12.2.8.1 USA Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.2.8.2 USA Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.2.8.3 USA Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.2.8.4 USA Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.2.8.5 USA Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.2.9 Canada
12.2.9.1 Canada Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.2.9.2 Canada Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.2.9.3 Canada Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.2.9.4 Canada Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.2.9.5 Canada Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.2.10 Mexico
12.2.10.1 Mexico Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.2.10.2 Mexico Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.2.10.3 Mexico Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.2.10.4 Mexico Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.2.10.5 Mexico Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.3 Europe
12.3.1 Trends Analysis
12.3.2 Europe Lab-Based IVD Market Estimates And Forecasts, By Country (2021-2032) (USD Billion)
12.3.3 Europe Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.3.4 Europe Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.3.5 Europe Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.3.6 Europe Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.3.7 Europe Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.3.8 Poland
12.3.8.1 Poland Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.3.8.2 Poland Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.3.8.3 Poland Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.3.8.4 Poland Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.3.8.5 Poland Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.3.9 Turkey
12.3.9.1 Turkey Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.3.9.2 Turkey Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.3.9.3 Turkey Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.3.9.4 Turkey Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.3.9.5 Turkey Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.3.10 Germany
12.3.10.1 Germany Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.3.10.2 Germany Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.3.10.3 Germany Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.3.10.4 Germany Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.3.10.5 Germany Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.3.11 France
12.3.11.1 France Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.3.11.2 France Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.3.11.3 France Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.3.11.4 France Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.3.11.5 France Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.3.12 UK
12.3.12.1 UK Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.3.12.2 UK Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.3.12.3 UK Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.3.12.4 UK Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.3.12.5 UK Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.3.13 Italy
12.3.13.1 Italy Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.3.13.2 Italy Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.3.13.3 Italy Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.3.13.4 Italy Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.3.13.5 Italy Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.3.14 Spain
12.3.14.1 Spain Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.3.14.2 Spain Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.3.14.3 Spain Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.3.14.4 Spain Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.3.14.5 Spain Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.3.15 Rest Of Europe
12.3.15.1 Rest Of Western Europe Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.3.15.2 Rest Of Western Europe Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.3.15.3 Rest Of Western Europe Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.3.15.4 Rest Of Western Europe Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.3.15.5 Rest Of Western Europe Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.4 Asia Pacific
12.4.1 Trends Analysis
12.4.2 Asia Pacific Lab-Based IVD Market Estimates And Forecasts, By Country (2021-2032) (USD Billion)
12.4.3 Asia Pacific Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.4.4 Asia Pacific Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.4.5 Asia Pacific Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.4.6 Asia Pacific Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.4.7 Asia Pacific Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.4.8 China
12.4.8.1 China Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.4.8.2 China Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.4.8.3 China Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.4.8.4 China Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.4.8.5 China Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.4.9 India
12.4.9.1 India Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.4.9.2 India Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.4.9.3 India Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.4.9.4 India Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.4.9.5 India Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.4.10 Japan
12.4.10.1 Japan Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.4.10.2 Japan Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.4.10.3 Japan Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.4.10.4 Japan Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.4.10.5 Japan Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.4.11 South Korea
12.4.11.1 South Korea Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.4.11.2 South Korea Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.4.11.3 South Korea Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.4.11.4 South Korea Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.4.11.5 South Korea Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.4.12 Singapore
12.4.12.1 Singapore Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.4.12.2 Singapore Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.4.12.3 Singapore Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.4.12.4 Singapore Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.4.12.5 Singapore Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.4.13 Australia
12.4.13.1 Australia Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.4.13.2 Australia Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.4.13.3 Australia Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.4.13.4 Australia Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.4.13.5 Australia Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.4.14 Rest Of Asia Pacific
12.4.14.1 Rest Of Asia Pacific Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.4.14.2 Rest Of Asia Pacific Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.4.14.3 Rest Of Asia Pacific Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.4.14.4 Rest Of Asia Pacific Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.4.14.5 Rest Of Asia Pacific Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.5 Middle East And Africa
12.5.1 Trends Analysis
12.5.2 Middle East And Africa Lab-Based IVD Market Estimates And Forecasts, By Country (2021-2032) (USD Billion)
12.5.3 Middle East And Africa Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.5.4 Middle East And Africa Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.5.5 Middle East And Africa Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.5.6 Middle East And Africa Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.5.7 Middle East And Africa Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.5.8 UAE
12.5.8.1 UAE Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.5.8.2 UAE Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.5.8.3 UAE Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.5.8.4 UAE Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.5.8.5 UAE Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.5.9 Saudi Arabia
12.5.9.1 Saudi Arabia Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.5.9.2 Saudi Arabia Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.5.9.3 Saudi Arabia Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.5.9.4 Saudi Arabia Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.5.9.5 Saudi Arabia Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.5.10 Qatar
12.5.10.1 Qatar Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.5.10.2 Qatar Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.5.10.3 Qatar Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.5.10.4 Qatar Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.5.10.5 Qatar Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.5.11 South Africa
12.5.11.1 South Africa Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.5.11.2 South Africa Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.5.11.3 South Africa Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.5.11.4 South Africa Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.5.11.5 South Africa Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.5.12 Rest Of Africa
12.5.12.1 Rest Of Africa Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.5.12.2 Rest Of Africa Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.5.12.3 Rest Of Africa Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.5.12.4 Rest Of Africa Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.5.12.5 Rest Of Africa Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.6 Latin America
12.6.1 Trends Analysis
12.6.2 Latin America Lab-Based IVD Market Estimates And Forecasts, By Country (2021-2032) (USD Billion)
12.6.3 Latin America Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.6.4 Latin America Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.6.5 Latin America Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.6.6 Latin America Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.6.7 Latin America Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.6.8 Brazil
12.6.8.1 Brazil Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.6.8.2 Brazil Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.6.8.3 Brazil Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.6.8.4 Brazil Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.6.8.5 Brazil Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.6.9 Argentina
12.6.9.1 Argentina Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.6.9.2 Argentina Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.6.9.3 Argentina Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.6.9.4 Argentina Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.6.9.5 Argentina Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
12.6.10 Rest Of Latin America
12.6.10.1 Rest Of Latin America Lab-Based IVD Market Estimates And Forecasts, By Product Type (2021-2032) (USD Billion)
12.6.10.2 Rest Of Latin America Lab-Based IVD Market Estimates And Forecasts, By Technique (2021-2032) (USD Billion)
12.6.10.3 Rest Of Latin America Lab-Based IVD Market Estimates And Forecasts, By Sample Type (2021-2032) (USD Billion)
12.6.10.4 Rest Of Latin America Lab-Based IVD Market Estimates And Forecasts, By Application (2021-2032) (USD Billion)
12.6.10.5 Rest Of Latin America Lab-Based IVD Market Estimates And Forecasts, By End-User (2021-2032) (USD Billion)
13. Company Profiles
13.1 F. Hoffmann-La Roche Ltd.
13.1.1 Company Overview
13.1.2 Financial
13.1.3 Products/ Services Offered
13.1.4 SWOT Analysis
13.2 Abbott
13.2.1 Company Overview
13.2.2 Financial
13.2.3 Products/ Services Offered
13.2.4 SWOT Analysis
13.3 Thermo Fisher Scientific Inc.
13.3.1 Company Overview
13.3.2 Financial
13.3.3 Products/ Services Offered
13.3.4 SWOT Analysis
13.4 Sysmex Corporation
13.4.1 Company Overview
13.4.2 Financial
13.4.3 Products/ Services Offered
13.4.4 SWOT Analysis
13.5 Siemens Healthineers AG
13.5.1 Company Overview
13.5.2 Financial
13.5.3 Products/ Services Offered
13.5.4 SWOT Analysis
13.6 BD
13.6.1 Company Overview
13.6.2 Financial
13.6.3 Products/ Services Offered
13.6.4 SWOT Analysis
13.7 QIAGEN
13.7.1 Company Overview
13.7.2 Financial
13.7.3 Products/ Services Offered
13.7.4 SWOT Analysis
13.8 Bio-Rad Laboratories Inc.
13.8.1 Company Overview
13.8.2 Financial
13.8.3 Products/ Services Offered
13.8.4 SWOT Analysis
13.9 Seegene Inc.
13.9.1 Company Overview
13.9.2 Financial
13.9.3 Products/ Services Offered
13.9.4 SWOT Analysis
13.10 DiaSorin S.p.A.
13.10.1 Company Overview
13.10.2 Financial
13.10.3 Products/ Services Offered
13.10.4 SWOT Analysis
14. Use Cases and Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments
By Product Type
Instruments
Reagents & Consumables
By Technique
Immunodiagnostics
Clinical Chemistry
Molecular Diagnostics
Hematology
Others
By Sample Type
Blood
Urine
Saliva
Tissue
Others
By Application
Infectious Diseases
Cardiology
Oncology
Gastroenterology
Allergy
Autoimmunity
Prenatal Screening
Others
By End-User
Hospitals
Clinical Laboratories
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Poland
Turkey
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
UAE
Saudi Arabia
Qatar
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g., Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players